Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study

Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study

(2013) Ju-Young Shin et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes

(2013) Glen I. Spielmans et al.   PLOS MEDICINE

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Association of Stroke with the Receptor-Binding Profiles of Antipsychotics—A Case-Crossover Study

(2012) Chi-Shin Wu et al.   BIOLOGICAL PSYCHIATRY

Depression and heart disease in US adults

(2012) Ashwini Niranjan et al.   GENERAL HOSPITAL PSYCHIATRY

Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study

(2012) Bart C Kleijer et al.   HEART

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

(2012) Stefan Leucht et al.   LANCET

Review: Risk of Cerebrovascular Adverse Events and Death in Elderly Patients With Dementia When Treated With Antipsychotic Medications: A Literature Review of Evidence

(2011) Vikrant Mittal et al.   American Journal of Alzheimers Disease and Other Dementias

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

(2011) Ruth Brauer et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

(2011) M. De Hert et al.   BRITISH JOURNAL OF PSYCHIATRY

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

(2011) M. De Hert et al.   EUROPEAN PSYCHIATRY

Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

(2011) Alicia Ruelaz Maher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Depression and Risk of Stroke Morbidity and Mortality

(2011) An Pan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

(2011) A. J. Mitchell et al.   PSYCHOLOGICAL MEDICINE

Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs

(2010) Emilio Sacchetti et al.   DRUG SAFETY

Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the Elderly

(2010) Nicole L. Pratt et al.   DRUGS & AGING

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Antipsychotic drugs and obesity

(2010) Christoph U. Correll et al.   TRENDS IN MOLECULAR MEDICINE

Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression

(2009) Francisco J Diaz et al.   BIPOLAR DISORDERS

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al.

(2009) E. Sacchetti et al.   JOURNAL OF PSYCHOPHARMACOLOGY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Risk of cerebrovascular events in elderly users of antipsychotics

(2008) BC Kleijer et al.   JOURNAL OF PSYCHOPHARMACOLOGY